An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

• Status: Completed
• Trial end date: 2008-04-01

Summary

Flutiform® compared with the individual components Flixotide® (Fluticasone) and Foradil® (Formoterol) in adolescent and adult patients.

• Phase: Phase 3

Details

• Lead Sponsor: Mundipharma Research Limited
• Treatments: Fluticasone; Formoterol Fumarate